APhA names winners of 2018 Immunization Champions Awards
The American Pharmacists Association has announced the winners of its 2018 Immunization Champions Awards. The awards recognize pharmacists and organizations that have made notable contributions to improving their communities’ vaccination rates.
“The APhA Immunization Champion Awards program helps us tell the story regarding pharmacists’ contributions to and impact on the health of communities and as valued members of the immunization neighborhood,” APhA chief strategy officer Mitchel Rothholz said. “This year is the 10th anniversary for presentation of the awards. We applaud the more than 320,000 pharmacists trained to administer vaccines and who are making a difference in their communities.”
The Washington, D.C.-based organization has been granting the awards for 10 years, and this year they were supported by Merck, Sanofi Pasteur and Seqirus. They consist of six categories — Individual Practitioners, Friend of Pharmacy immunization efforts, Corporation/ Institution, Partnership, Community Outreach and Pharmacy Team Member. APhA said it evaluated nominees based on the areas of impact, originality and opportunities created for pharmacists, among other criteria.
The winners and honorable mentions are:
Winners: Andrew DeMotto of Whiteriver, Ariz., and Holly Gurgle of Salt Lake City, Utah.
Honorable mention: Tuong-Lan Nguyen of Broken Arrow, Okla., and Luis Rosado of Morovis, Puerto Rico
Friend of Pharmacy
Winner: Kimberly Battreall of Omaha, Neb.
Outstanding Career Achievement
Winner: William Atkinson of Saint Paul, Minn.
Winner: Albertsons, based in Boise, Idaho
Honorable mention: Fred’s, based in Arlington, Tenn.
Winner: Seattle’s Project VACCINATE
Winner: Reeves-Sain Drug Store in Murfreesboro, Tenn.
Honorable mention: Brandy Turner of Richmond, VA)
Pharmacy team member
Winner: Cecilia Dudero of Santa Clara, Calif.
Impax launches authorized Solodyn generic
Impax Labs has launched its authorized Solodyn generic (minocycline HCl, extended-release tablets). The drug is indicated to treat only inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients ages 12 years and older.
Impax’s authorized Solodyn generic will be available in 65- and 115-mg dosage strength. The product had U.S. sales of roughly $148 million for the 12 months ended December 2017, according to IQVIA data.
Amneal’s generic Namenda XR introduced
Amneal’s generic Namenda XR (memantine hydrochloride extended release) capsules have launched in four dosage strengths. The drug is indicated for the treatment of moderate-to-sever dementia of the Alzheimer’s type.
Amneal’s generic Namenda XR will be available in 7-, 14-, 21- and 28-mg dosage strengths. The product had U.S. sales of roughly $929 million for the 12 months ended December 2017, according to IQVIA data.